Rheumatoid Arthritis
Conditions
Interventions
Sponsors
Temporarily not sure
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18 to 75 years old; (2) Meet the diagnostic criteria of Rheumatoid Arthritis.
Exclusion criteria
Exclusion criteria: (1) the overlapping other rheumatism, such as systemic lupus erythematosus (sle) and sjogren's syndrome, severe patients with knee osteoarthritis, etc; (2) patients with bleeding tendency, gastrointestinal bleeding or other chronic hemorrhagic diseases within the past month; (3) women who are pregnant or breast-feeding; (4) allergic constitution or known components of the drug; (5) patients with serious diseases of heart, lung, liver, kidney, hematopoietic system, immune system, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Related symptoms and signs; | — |
Secondary
| Measure | Time frame |
|---|---|
| HAQ scores;Blood sedimentation rate (ESR), rheumatoid factor (RF), and c-reactive protein (CRP) were examined;T lymphocyte subsets (CD3+, CD4+, CD8+, CD4+/CD8+);Observation on signs and symptoms of rheumatoid arthritis;VAS quantized integral; | — |
Countries
China
Contacts
Public ContactHe Yanlin
Hinye Pharmaceutical Co., Ltd
Outcome results
None listed